GLP-1 Semaglutide is the active ingredient found in the brand-name medication Wegovy®, an FDA-approved, prescription-only medication for weight loss. Research has proved that Semaglutide patients have noteworthy weight loss, averaging a 14.9% decrease from primary body weight without limiting diet or extreme exercise. Moreover, one-third of Semaglutide using patients lost at least 20% of baseline mass, demonstrating a 60-pound weight loss for a 300 pound patient.